Archives - Research Network

Governing Structure of the PGRN, 2000-2003
A steering committee oversees the conduct of the NIH Pharmacogenetics Research Network. This is the original operating structure, with periodic turnover in leadership.

• Steering Committee
  • Policy Statements
  • Coordinating Committee
  • Human Subjects Subcommittee
  • Intellectual Property Subcommittee
  • Communications Subcommittee
    • Fourth Open Scientific Meeting
    • Third Open Scientific Meeting
    • Second Open Scientific Meeting
    • First Open Scientific Meeting
  • Knowledge Base Subcommittee

External Scientific Panel for the PGRN, 2003-2005 
The ESP was created in 2003, and is a standing group with which the network interacts to obtain advice. The purpose of the group is to assist the investigators in thinking broadly and to help push the science forward.

• ESP Group Members

• Charge to the ESP

Interest Groups of the PGRN, 2003-2005
The Interest Groups provide the focal points for scientific discussions in the Research Network. This structure was conceived by the network in 2002, and is being tested.

• Resource and Expertise Groups
  • Haplotyping, Genotyping, Comparative Genomics
  • Population Genetics, Study Design, Statistics
  • Tissue Resources, Study Populations
  • Phenotyping Technologies/Pharmacokinetics
• Disease Focus Groups
  • Cancer
  • Cardiovascular-Pulmonary Signaling Systems
  • Adverse Drug Reactions
• Interest Groups Coordination

Industry Input, 2000-2003
NIGMS has solicited pharmaceutical industry perspective on pharmacogenetics research. Expressions of interest are accepted at any time.

• Letter of Invitation
  Self-nominations (curriculum vitae and cover letter)
  • 2001 letter of invitation
  • 2000 letter of invitation
• Summary of the Second Industry Liaison Group Meeting
• Summary of the First Industry Liaison Group Meeting